• News Archive
  • Simaster
  • Webmail
  • Directory
  • Crisis Center
  •  English
    • Indonesia
Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada
  • Education
    • Doctoral dissertation
    • Inauguration of Professor
    • Graduation
  • Achievement
  • Research and Innovation
    • Research
    • Innovation
  • Campus Info
    • Cooperation
    • Seminar and Workshop
    • Student Community Service Program
    • Other
  • News Report
  • Home
  • News Report
  • Drug Repurposing as an Alternative for Covid-19 Antiviral

Drug Repurposing as an Alternative for Covid-19 Antiviral

  • 07 April 2021, 10:22 WIB
  • By: Natasa Adelayanti
  • 1674
  • PDF Version
Antivirus Covid-19 Belum Ditemukan, Terapi Masih Gunakan Drug Repurposing

Covid has had a tremendous effect around the world. The number of dead people has reached up to millions. This condition made researchers and scientists initiated to find Covid-19 antiviral. A professor from the UGM Faculty of Pharmacy, Prof. Dr. Apt. Djoko Wahyono, SU., revealed that there had been no effective specific antiviral proposed for Covid-19 until now. Most of the drugs used for clinical trials for Covid-19 are repurposing drugs. Those are drugs that were once released with Emergency Use Authorization (EUA) for Covid-19 therapy, considering there have been no drugs purely dedicated for Covid-19. The products used for repurposing drugs including chloroquine/hydroxychloroquine, lopinavir/ritonavir, ribavirin, oseltamivir, umifenovir, remdesivir, and favipiravir (avigan).

"More than 600 clinical trials around the world are using drug repurposing," he explained in the full-time webinar entitled "Molecular Detection of Viruses and Development and Clinical Trials of Antiviral Drugs In Stopping Covid-19 Transmission" on Tuesday (6/4). He also added no antiviral drug of Covid-19 issued by The National Agency of Drug and Food Control or BPOM up to the present.

"The advantage of using repurposing drugs is to expedite the discovery of the Covid-19 drug to be proceeded to clinical trial in the third phase considering the drug security has been discovered," he said.

He also added that the clinical trial was considered important because it tests its function in humans. This phase should be under good clinical practice to guarantee the data and results must be accurate. Besides, the guarantee of integrity rights and the confidentiality of clinical trial subjects must be provided.

On the other hand, Pharmacist Chemist, UGM Faculty of Pharmacy, Prof. Dr. Apt. Kuswandi, SU., M.Phil, revealed the plant's potential as a source to develop synthetic antiviral drugs. In fact, Indonesia is the second country with the biggest Biodiversity after Brazil.

"Indonesia has abundant natural resources. There are 940 species of medicinal plants in our forests," he explained.

Kuswandi admitted that Indonesia still imported the raw materials for Covid-19 drugs from abroad. In fact, it has abundant species of medicinal plants and is the potential to develop on its own. Another Pharmacist Chemist expert in the Faculty of Pharmacy, Prof. Dr. Apt., Sismindari, SU., explained SARS Cov 2 molecular detection development. She revealed two steps in identifying specific virus molecules or those in the host due to infection. First is using protein levels such as antibody test and antigen. Those are designed to detect SARS Cov 2 protein produced by the virus replicated within the infected body. Secondly, detection at nucleic acid levels of both RNA and DNA.

Additionally, there was also UGM Epidemiologist, dr. Riris Andono Ahmad, MD., MPH., Ph.D. He said that Covid transmission continued to happen because the community has no immunity. Furthermore, people's mobility is increasing. However, today, the government appeals to the public to keep implementing health protocols (3M, 3T, PSBB) and vaccination. He added that the vaccination was very potential to reduce Covid-19 transmission.

"Nonetheless, it does not mean vaccines can totally overcome the pandemic. It only has higher effectiveness to reduce new cases, pain, and the number of deaths," he concluded.

Author: Ika
Photo: Illustration

Related News

  • BPOM Approves Avivavir for Coronavirus Treatment

    Monday,29 March 2021 - 11:58
  • UGM Develops Antiviral Drug for Coronavirus

    Thursday,03 December 2020 - 8:20
  • UGM Expert: Remdesivir is Only for Emergency Use

    Monday,05 October 2020 - 16:32
  • Ask Prescription from Doctor If You Want to Consume Chloroquine

    Monday,23 March 2020 - 22:00
  • UGM Professor Reckons Eucalyptus Necklace Is Not Yet Proven As Anti-Covid-19

    Monday,06 July 2020 - 17:57

News Releases

  • UGM Medical Students Win 2022 RespiQuizz 27 June 2022
    UGM medical students Azaria Evan Trie Tana and Wisnu Pinan
    Salma
  • UGM Ready for 2022 Formula Student Netherlands 22 June 2022
    The UGM formula team Bimasakti is set to compete at
    Salma
  • German President Frank-Walter Steinmeier Visits Universitas Gadjah Mada 17 June 2022
    Universitas Gadjah Mada (UGM) received a visit from German
    Salma
  • UGM Claims Sixth Place at 2022 CanSat Competition 17 June 2022
    The Narantaka Gadjah Mada Aerospace Team (GMAT) finished i
    Salma
  • IR Graduate Angelo Wijaya Named Global Winner of 2022 World Bank Group Youth Summit’s Case Challenge 16 June 2022
    Angelo Wijaya, an alumnus of the UGM International Relatio
    Salma

Info

  • Install Fest Windows
    29 September 2017
  • Streaming Author Workshop Writing and Publishing
    14 July 2017
  • Hokkaido University Short Term Exchange Program HUSTEP
    08 January 2016
  • 2016 Amgen Scholars Program in Japan
    08 January 2016
  • Jardine Foundation Scholarship for Postgraduate Studies at University of Oxford and University of Cambridge
    01 July 2015

Event

  • 21Jul The International Conference on Sustainable Environment, Agriculture, and Tourism (ICOSEAT)...
  • 07Sep The 8th International Conference on Science and Technology (ICST 2022)...
Universitas Gadjah Mada
UNIVERSITAS GADJAH MADA
Bulaksumur Yogyakarta 55281
   info@ugm.ac.id
   +62 (274) 588688
   +62 (274) 565223
   +62 811 2869 988

PARTNERSHIP

  • Alumni
  • International Affairs

ABOUT UGM

  • Rector's Welcome
  • History
  • Vission and Mission
  • The Board of Executive
  • Management

VISIT UGM

  • Campus Map
  • Event

REGISTRATION

  • Undergraduate
  • Graduate
  • Vocational School
  • Professional Program
  • International Program

© 2022 Universitas Gadjah Mada

PRIVACY POLICYCONTACT